BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
ARS Pharmaceuticals
SPRY
$606M
| $27.2M | ﹤0.01% |
2,658,239
+20,690
| +0.8% | +$154K |
|
|
SFIX
2802
Stitch Fix
SFIX
$474M
| $27.1M | ﹤0.01% |
10,257,787
+213,491
| +2% | +$657K |
|
|
MOMO
2803
Hello Group
MOMO
$867M
| $27.1M | ﹤0.01% |
4,359,251
+115,694
| +3% | +$734K |
|
|
OSG
2804
DELISTED
Overseas Shipholding Group Inc.
OSG
| $27M | ﹤0.01% |
4,226,265
-203,358
| -5% | -$1.21M |
|
2805
Arbutus Biopharma
ABUS
$908M
| $26.8M | ﹤0.01% |
10,404,619
+14,319
| +0.1% | +$37.1K |
|
2806
Coherus Oncology
CHRS
$181M
| $26.8M | ﹤0.01% |
11,230,522
-844,173
| -7% | -$2.08M |
|
|
AGS
2807
DELISTED
PlayAGS
AGS
| $26.8M | ﹤0.01% |
2,981,280
-77,991
| -3% | -$681K |
|
2808
iShares Convertible Bond ETF
ICVT
$7.64B
| $26.6M | ﹤0.01% |
333,545
+275,734
| +477% | +$21.5M |
|
2809
WPP
WPP
$5.82B
| $26.5M | ﹤0.01% |
560,055
+161,568
| +41% | +$7.61M |
|
|
DSKE
2810
DELISTED
Daseke, Inc. Common Stock
DSKE
| $26.5M | ﹤0.01% |
3,190,418
+133,983
| +4% | +$1.1M |
|
2811
Garrett Motion
GTX
$5.47B
| $26.5M | ﹤0.01% |
2,662,963
-181,157
| -6% | -$1.67M |
|
2812
Boston Omaha
BOC
$436M
| $26.4M | ﹤0.01% |
1,705,173
-17,917
| -1% | -$282K |
|
2813
Prime Medicine
PRME
$580M
| $26.3M | ﹤0.01% |
3,756,210
-22,408
| -0.6% | -$170K |
|
2814
Gerdau
GGB
$9.48B
| $26.3M | ﹤0.01% |
7,132,343
-1,840,092
| -21% | -$6.66M |
|
2815
iShares Large Cap Deep Quarterly Laddered ETF
IVVB
$133M
| $26.3M | ﹤0.01% |
950,000
+760,000
| +400% | +$20.4M |
|
2816
Nomura Holdings
NMR
$29B
| $26.2M | ﹤0.01% |
4,082,259
+410,820
| +11% | +$2.28M |
|
2817
Axogen
AXGN
$2.67B
| $26.1M | ﹤0.01% |
3,232,207
-110,566
| -3% | -$990K |
|
|
TARO
2818
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $26.1M | ﹤0.01% |
615,581
-7,402
| -1% | -$312K |
|
2819
Oil-Dri
ODC
$1.27B
| $26.1M | ﹤0.01% |
698,996
-28,304
| -4% | -$975K |
|
|
AUTL
2820
Autolus Therapeutics
AUTL
$564M
| $25.9M | ﹤0.01% |
4,055,920
+2,700,581
| +199% | +$16.8M |
|
|
TAST
2821
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $25.9M | ﹤0.01% |
2,720,087
-699,233
| -20% | -$6.46M |
|
2822
Tenaris
TS
$26.8B
| $25.8M | ﹤0.01% |
656,960
-482,727
| -42% | -$16.7M |
|
2823
Cerus
CERS
$572M
| $25.8M | ﹤0.01% |
13,636,954
-91,442
| -0.7% | -$186K |
|
2824
UroGen Pharma
URGN
$2.39B
| $25.8M | ﹤0.01% |
1,716,813
-2,491
| -0.1% | -$40.7K |
|
|
GPMT
2825
Granite Point Mortgage Trust
GPMT
$58.8M
| $25.6M | ﹤0.01% |
5,371,355
-22,889
| -0.4% | -$119K |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.